Market Crash Alert: How the Cannabis Bubble Affects All Stocks

Learn how the cannabis bubble tells us what is to come, using Canopy Growth Corp (TSX:WEED)(NYSE:CGC) as an example.

Investors that have lost their shirts with various Canadian cannabis stocks over the past year can attest the pain of a bubble and stock prices. Valuations are now at levels that, by some metrics, are at all-time highs. Therefore, investors ought to be more cautious with making large investments in any company right now. In this article, I’m going to discuss some of the lessons learned from the cannabis bubble, which we saw pop recently.

Earnings matter

The “growth-at-any-price” investment mandate of so many momentum investors in 2018 and 2019 led to valuation increases. In hindsight, these increases were absurd for cannabis stocks. Expectations of revenue growth and eventual profitability in a year or two (this year or next) determined stock prices rather than fundamentals.

Cannabis producers were scrambling to acquire production capacity at any cost. They had no regard for profitability at the time. There was a marked shift in investor sentiment related to the weaker-than-expected revenue growth. This was ultimately tied to demand that did not materialize. Subsequently, stock prices plummeted. As many investors have seen, some cannabis producers have seen stock price declines north of 90% from their peaks.

The overall stock market today is by no means as irresponsibly priced as the cannabis sector was 18 months ago. That said, some of the same concerns of growth expectations being way too bullish and demand failing to materialize are real.

The rebound in demand for almost any good right now that is being priced into the stock market is, in my opinion, unrealistic. Investors should pay attention to the structural economic issues that are likely to influence earnings when making assessments of the value of any company.

Cost cutting is not bullish

As we have seen with one of Canada’s largest cannabis producers, Canopy Growth, cost cutting has become the name of the game in the cannabis sector. Instead of adding production capacity, companies like Canopy have been shuttering plants and laying off workers. Their goal is to widen margins and produce cash flow and profitability sooner.

The sharp fall out of expected demand has created an environment in which survival has become the primary goal of management teams across the sector. Even these management teams have seen significant turnover of late.

I expect we’ll see similar measures take hold in a swath of sectors in the coming quarters. Consumer and corporate demand for goods and services will flatline or decline. This potential spiral, similar to the one experienced in the cannabis sector, would be structural.

This means monetary and fiscal stimulus measures would likely not have the desired impact investors today are banking on. A reduction in the efficacy of government intervention in the economy is not in any way priced into the stock market right now. Lowering interest rates to below zero, for example, is unlikely to persuade a company to hire back thousands of laid-off employees. However, you couldn’t tell that by watching how stocks react to stimulus news.

Stay Foolish, my friends.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »